September 15 -18, 2025
Hynes Convention CenterBoston, USA Elisabeth KrugExecutive Director, BRD Analytical Development at Eli Lilly & CompanySpeaker
Profile
Dr. Elisabeth Krug graduated from the University of Würzburg, Germany, in 1994 as a pharmaceutical biologist. She started with Lilly in 1995 as an analytical scientist in the small molecule development. She then took an assignment in Six Sigma becoming a Master Black Belt. Since 2010, Dr. Krug has been extensively working with biomolecules, where she is responsible to support the analytical development and control strategy definition for biomolecules.
Agenda Sessions
Ensuring Product Comparability & Accelerating Analytical Method Development: Bridging Early and Late-Phase Development
, 11:30amView Session